Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (641-650 of 1,833) with videos related to

Pageof 184
Sort By:
Mabs|January 15, 2010
Antibody drug-conjugates targeting the tumor vasculature: Current and future developmentsHans-Peter Gerber, Peter D Senter, Iqbal S Grewal
Mabs|January 16, 2010
Monoclonal antibodies and progressive multifocal leukoencephalopathyJoseph R Berger, Sidney A Houff, Eugene O Major
Mabs|January 16, 2010
Human immunoglobulin allotypes: possible implications for immunogenicityRoy Jefferis, Marie-Paule Lefranc
Mabs|January 5, 2010
Practical considerations for nonclinical safety evaluation of therapeutic monoclonal antibodiesCarmel M Lynch, Bruce W Hart, Iqbal S Grewal
Mabs|January 5, 2010
Antibodies targeting cancer stem cells: a new paradigm in immunotherapy?Mahendra P Deonarain, Christina A Kousparou, Agamemnon A Epenetos
Mabs|January 5, 2010
New challenges to medicare beneficiary access to mAbsJoshua Cohen, Andrew Wilson
Mabs|January 5, 2010
Antibodies designed as effective cancer vaccinesR L Metheringham, V A Pudney, B Gunn, et al.
Mabs|January 15, 2015
Evaluation of cetuximab as a candidate for targeted α-particle radiation therapy of HER1-positive disseminated intraperitoneal diseaseDiane E Milenic, Kwamena E Baidoo, Young-Seung Kim, et al.
Mabs|December 17, 2014
Early developability screen of therapeutic antibody candidates using Taylor dispersion analysis and UV area imaging detectionAlexandra Lavoisier, Jean-Marc Schlaeppi
Mabs|December 18, 2014
In vitro and in vivo modifications of recombinant and human IgG antibodiesHongcheng Liu, Gomathinayagam Ponniah, Hui-Min Zhang, et al.
Pageof 184

Showing results (641-650 of 1,833) with videos related to

Sort By:
Pageof 184
Mabs|January 15, 2010
Antibody drug-conjugates targeting the tumor vasculature: Current and future developmentsHans-Peter Gerber, Peter D Senter, Iqbal S Grewal
Mabs|January 16, 2010
Monoclonal antibodies and progressive multifocal leukoencephalopathyJoseph R Berger, Sidney A Houff, Eugene O Major
Mabs|January 16, 2010
Human immunoglobulin allotypes: possible implications for immunogenicityRoy Jefferis, Marie-Paule Lefranc
Mabs|January 5, 2010
Practical considerations for nonclinical safety evaluation of therapeutic monoclonal antibodiesCarmel M Lynch, Bruce W Hart, Iqbal S Grewal
Mabs|January 5, 2010
Antibodies targeting cancer stem cells: a new paradigm in immunotherapy?Mahendra P Deonarain, Christina A Kousparou, Agamemnon A Epenetos
Mabs|January 5, 2010
New challenges to medicare beneficiary access to mAbsJoshua Cohen, Andrew Wilson
Mabs|January 5, 2010
Antibodies designed as effective cancer vaccinesR L Metheringham, V A Pudney, B Gunn, et al.
Mabs|January 15, 2015
Evaluation of cetuximab as a candidate for targeted α-particle radiation therapy of HER1-positive disseminated intraperitoneal diseaseDiane E Milenic, Kwamena E Baidoo, Young-Seung Kim, et al.
Mabs|December 17, 2014
Early developability screen of therapeutic antibody candidates using Taylor dispersion analysis and UV area imaging detectionAlexandra Lavoisier, Jean-Marc Schlaeppi
Mabs|December 18, 2014
In vitro and in vivo modifications of recombinant and human IgG antibodiesHongcheng Liu, Gomathinayagam Ponniah, Hui-Min Zhang, et al.
Pageof 184